Abstract
Development of cyclodextrins as enabling excipients began decades ago and during this time a conventional view of the substrate–cyclodextrin interaction was formed that has persisted in spite of numerous contradicting observations. Here the shortcomings of the phase-solubility method are elucidated. The limited permeability of drug/cyclodextrin complexes through semi-permeable membrane, as well as osmometric data and images from transition electronic microscopy (TEM) are used as convincing evidences of aggregation of cyclodextrins and their complexes. The necessity of updating the existing notions of cyclodextrin complexation is discussed.
Similar content being viewed by others
References
Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325–1357 (1997)
Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–212 (1965)
Aicart, E., Junquera, E.: Complex formation between purine derivatives and cyclodextrins: a fluorescence spectroscopy study. J. Incl. Phenom. Macrocycl. Chem. 47, 161–165 (2003)
Masson, M., Sigurjonsdottir, J.F., Jonsdottir, S., Loftsson, T.: Examination of 19F-NMR as a tool for investigation of drug-cyclodextrin complexes. Drug Dev. Ind. Pharm. 29, 107–112 (2003)
Morin, N., Cornet, S., Guinchard, C., Rouland, J.-C., Guillaume, Y.C.: HPLC retention and inclusion of imidazole derivatives using hydroxypropyl-β-cyclodextrin as a mobile phase additive. J. Liq. Chromatogr. Relat. Technol. 23, 727–739 (2000)
Perlovich, G.L., Skar, M., Bauer-Brandl, A.: Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD. Eur. J. Pharm. Sci. 20, 197–200 (2003)
Masson, M., Loftsson, T., Jonsdottir, S., Fridriksdottir, H., Petersen, D.S.: Stabilization of ionic drugs through complexation with nonionic and ionic cyclodextrins. Int. J. Pharm. 164, 45–55 (1998)
Masson, M., Sigurdardottir, B.V., Matthiasson, K., Loftsson, T.: Investigation of drug–cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations. Chem. Pharm. Bull. 53, 958–964 (2005)
Ugwu, S.O., Alcala, M.J., Bhardwaj, R., Blanchard, J.: The application of equilibrium dialysis to the determination of drug-cyclodextrin stability constants. J. Incl. Phenom. Mol. Recognit. Chem. 25, 173–176 (1996)
Loftsson, T., Magnusdottir, A., Masson, M., Sigurjonsdottir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307–2316 (2002)
Kurkov, S.V., Loftsson, T., Messner, M., Madden, D.: Parenteral delivery of HPβCD: effects on drug-HSA binding. AAPS PharmSciTech (in press)
Magnusdottir, A., Masson, M., Loftsson, T.: Self association and cyclodextrin solubilization of NSAIDs. J. Incl. Phenom. Macrocycl. Chem. 44, 213–218 (2003)
Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18–28 (2005)
Loftsson, T., Olafsdottir, B.J., Fridriksdottir, H., Jonsdottir, S.: Cyclodextrin complexation of NSAIDs: physicochemical characteristics. Eur. J. Pharm. Sci. 1, 95–101 (1993)
Oh, I., Lee, M.-Y., Lee, Y.-B., Shin, S.-C., Park, I.: Spectroscopic characterization of ibuprofen/2-hydroxypropyl-β-cyclodextrin inclusion complex. Int. J. Pharm. 175, 215–223 (1998)
Miyajima, K., Sawada, M., Nakagaki, M.: Viscosity B-coefficients, apparent molar volumes, and activity coefficients for α- and γ-cyclodextrins in aqueous solutions. Bull. Chem. Soc. Jpn. 56, 3556–3560 (1983)
Bonini, M., Rossi, S., Karlsson, G., Almgren, M., Lo Nostro, P., Baglioni, P.: Self-assembly of β-cyclodextrin in water. Part 1: cryo-TEM and dynamic and static light scattering. Langmuir 22, 1478–1484 (2006)
Szente, L., Szejtli, J., Kis, G.L.: Spontaneous opalescence of aqueous γ-cyclodextrin solutions: complex formation or self-aggregation? J. Pharm. Sci. 87, 778–781 (1998)
Witte, F., Hoffmann, H.: Aggregation behavior of hydrophobically modified β-cyclodextrins in aqueous solution. J. Incl. Phenom. Mol. Recognit. Chem. 25, 25–28 (1996)
Auzely-Velty, R., Djedaieni-Pilard, F., Desert, S., Perly, B., Zemb, T.: Micellization of hydrophobically modified cyclodextrins. 1. Micellar structure. Langmuir 16, 3727–3734 (2000)
Loftsson, T., Matthiasson, K., Masson, M.: The effects of organic salts on the cyclodextrin solubilization of drugs. Int. J. Pharm. 262, 101–107 (2003)
Loftsson, T., Masson, M., Sigurdsson, H.H.: Cyclodextrins and drug permeability through semi-permeable cellophane membranes. Int. J. Pharm. 232, 35–43 (2002)
Messner, M., Kurkov, S.V., Loftsson, T.: Self-assembled cyclodextrin aggregates and nanoparticles. Int. J. Pharm. 387(1–2), 199–208 (2010)
Jansook, P., Kurkov, S.V., Loftsson, T.: Cyclodextrins as solubilizers: formation of complex aggregates. J. Pharm. Sci. 99(2), 719–729 (2010)
Wu, A., Shen, X., He, Y.: Investigation on γ-cyclodextrin nanotube induced by N,N′-diphenylbenzidine molecule. J Colloid Interface Sci. 297, 525–533 (2006)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurkov, S.V., Ukhatskaya, E.V. & Loftsson, T. Drug/cyclodextrin: beyond inclusion complexation. J Incl Phenom Macrocycl Chem 69, 297–301 (2011). https://doi.org/10.1007/s10847-010-9756-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9756-x